Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P18
Within normal range
vs 2Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -14.81% |
| Q3 2025 | 5.26% |
| Q2 2025 | -7.55% |
| Q1 2025 | -231.25% |
| Q4 2024 | 57.89% |
| Q3 2024 | -8.57% |
| Q2 2024 | -12.90% |
| Q1 2024 | -1144.98% |
| Q4 2023 | 90.04% |
| Q3 2023 | 13.79% |
| Q2 2023 | 6.45% |
| Q1 2023 | 0.00% |
| Q4 2022 | -19.23% |
| Q3 2022 | 10.34% |
| Q2 2022 | 9.38% |
| Q1 2022 | -23.08% |
| Q4 2021 | -52.94% |
| Q3 2021 | 19.05% |
| Q2 2021 | 8.70% |
| Q1 2021 | -9.52% |
| Q4 2020 | -5.00% |
| Q3 2020 | 13.04% |
| Q2 2020 | 23.33% |
| Q1 2020 | 11.76% |
| Q4 2019 | 20.93% |
| Q3 2019 | 27.12% |
| Q2 2019 | 21.33% |
| Q1 2019 | 28.57% |
| Q4 2018 | 22.22% |
| Q3 2018 | 4.93% |
| Q2 2018 | -4.41% |
| Q1 2018 | -128.33% |
| Q4 2017 | 500.00% |
| Q3 2017 | 25.00% |
| Q2 2017 | 5.88% |
| Q1 2017 | 19.43% |
| Q4 2016 | 27.74% |
| Q3 2016 | -12.31% |
| Q2 2016 | 0.00% |
| Q1 2016 | -26.21% |